ÂÜÀòÂÒÂ×

Anthony Rohr currently serves as the Director of Business Development at Genesis Drug Discovery & Development (GD³) since February 2024. Previously, Rohr held the position of Chief Operating Officer at DSI - DS InPharmatics from June 2023 to February 2024 and at GD³ from September 2021 to June 2023. Rohr also served as Chief Executive Officer of PharmOptima™, a member of the Genesis Biotechnology Group, from July 2020 to June 2023, and as President and Owner of Knowledgeable and Focused Consulting, LLC, from November 2017 to June 2023. Additional roles include Business Development and Project Manager at PharmOptima™ from November 2018 to July 2020, and various laboratory operations positions at MPI Research from July 2003 to October 2017. Rohr began a career in research as a Research Technician 2 at Baylor College of Medicine and has experience in management as a Manager/bartender at Dyckman Saloon. Anthony Rohr earned a B.S. in Biomedical Sciences from Western Michigan University between 1998 and 2002.